Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Living With Dementia

hydrocephalus1 - brain amyloid imaging1 - perusini1 - failing memory1 - glucose hypometabolism1 - thomas willis1 - tavi2 - decline in cognitive functioning1 - thyroid disease1 - aricept1 - vecordia1 - reversible dementia1 - declines in memory1 - symptomatic memory loss1 - glucose metabolism2 - protein amyloid beta1 - cholesterol-lowering drugs1 - mental stimulation1 - memory disorders program1 - wernicke's-korsakoff syndrome10 - cognitive testing2 - alzheimer's symptoms2 - stages of atherosclerosis1 - leeza gibbons memory foundation1 - good sleep habits1 - vascular damage1 - management of delirium1 - prevent alzheimer's1 - alzheimer drug1 - biomarkers in cerebrospinal fluid1 -